6001

COM:TIANTANBIO

北京天坛生物制品股份有限公司

  • Stock

Last Close

22.03

22/11 07:00

Market Cap

47.00B

Beta: -

Volume Today

20.09M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
825.02M
-
846.51M
2.60%
879.34M
3.88%
972.16M
10.56%
949.89M
2.29%
1.30B
37.32%
1.83B
40.24%
2.06B
12.65%
2.16B
4.72%
2.24B
3.71%
2.59B
15.65%
average payables
164.35M
-
136.40M
17.00%
121.95M
10.60%
125.66M
3.04%
73.46M
41.54%
40.25M
45.21%
53.07M
31.85%
47.90M
9.76%
59.78M
24.81%
71.54M
19.68%
71.89M
0.48%
average receivables
387.57M
-
343.98M
11.25%
271.55M
21.06%
284.14M
4.64%
284.68M
0.19%
354.48M
24.52%
575.88M
62.46%
707.17M
22.80%
901.23M
27.44%
1.15B
27.35%
679.38M
40.81%
book value per share
1.28
-
1.29
1.39%
1.33
2.98%
1.45
8.42%
2.02
40.10%
2.25
11.22%
2.63
16.89%
3.00
14.17%
4.98
65.71%
5.29
6.26%
5.96
12.66%
capex per share
-0.36
-
-0.31
14.84%
-0.21
33.33%
-0.14
33.17%
-0.10
30.03%
-0.20
103.47%
-0.35
79.13%
-0.40
15.17%
-0.70
72.81%
-0.81
16.39%
-0.65
19.72%
capex to depreciation
-5.94
-
-4.17
29.91%
-1.54
63.15%
-1.02
33.28%
-1.41
38.05%
-2.26
59.90%
-4.10
81.57%
-4.59
11.75%
-7.20
57.00%
-7.53
4.61%
-3.79
49.73%
capex to operating cash flow
-0.97
-
-0.97
0.31%
-0.64
34.60%
-0.49
23.04%
-0.66
35.71%
-0.43
34.65%
-0.82
88.93%
-0.87
5.88%
-1.15
33.11%
-1.20
4.17%
-0.44
63.08%
capex to revenue
-0.30
-
-0.25
14.90%
-0.19
26.90%
-0.10
46.22%
-0.08
17.86%
-0.10
22.17%
-0.16
59.91%
-0.18
10.21%
-0.28
55.73%
-0.32
15.46%
-0.21
33.92%
cash per share
0.45
-
0.63
41.95%
0.36
43.58%
0.41
14.27%
1.17
185.49%
0.82
29.33%
0.91
10.52%
1.09
19.93%
2.61
138.95%
2.23
14.44%
2.76
23.76%
days of inventory on hand
404.55
-
384.51
4.95%
414.44
7.78%
372.44
10.13%
422.16
13.35%
402.90
4.56%
432.36
7.31%
457.16
5.74%
362.71
20.66%
392.24
8.14%
397.31
1.29%
days payables outstanding
72.55
-
54.41
25.01%
56.47
3.80%
45.68
19.12%
11.40
75.05%
13.25
16.28%
11.08
16.43%
9.65
12.85%
12.47
29.17%
11.67
6.39%
10.39
10.96%
days sales outstanding
76.07
-
60.99
19.83%
53.67
12.00%
57.54
7.21%
49.42
14.11%
58.52
18.42%
75.83
29.57%
77.60
2.34%
94.97
22.38%
104.97
10.54%
9.47
90.97%
debt to assets
0.38
-
0.43
15.00%
0.40
6.85%
0.41
0.13%
0.11
73.75%
0.05
57.19%
0.06
39.29%
0.11
67.42%
0.04
58.61%
0.03
29.12%
0.01
66.73%
debt to equity
1.11
-
1.35
21.83%
1.17
12.82%
1.07
9.03%
0.13
87.99%
0.07
46.64%
0.10
48.57%
0.18
74.32%
0.06
64.35%
0.05
27.48%
0.01
67.34%
dividend yield
0.01
-
0.01
6.58%
0.01
36.24%
0.00
32.28%
0.01
90.10%
0.01
12.02%
0.00
74.54%
0.00
14.49%
0.00
136.20%
0.00
5.09%
0.00
59.45%
earnings yield
0.03
-
0.01
71.41%
0.00
94.09%
0.01
2,131.56%
0.06
359.92%
0.03
49.48%
0.03
3.73%
0.02
41.40%
0.03
51.76%
0.03
11.50%
0.02
28.73%
enterprise value
12.44B
-
14.92B
19.93%
19.14B
28.29%
22.17B
15.83%
18.52B
16.48%
16.14B
12.84%
28.02B
73.61%
51.30B
83.08%
35.20B
31.39%
36.14B
2.67%
48.30B
33.65%
enterprise value over ebitda
17.03
-
24.54
44.07%
32.33
31.75%
28.82
10.86%
12.20
57.68%
16.10
31.96%
23.84
48.12%
41.34
73.39%
24.84
39.91%
22.64
8.84%
24.37
7.63%
ev to operating cash flow
21.96
-
31.21
42.14%
40.44
29.56%
51.75
27.97%
84.79
63.83%
23.81
71.92%
43.61
83.19%
73.07
67.53%
35.90
50.86%
32.09
10.61%
19.90
38.00%
ev to sales
6.77
-
8.17
20.59%
11.83
44.83%
10.58
10.58%
10.49
0.84%
5.51
47.51%
8.54
55.05%
14.89
74.38%
8.56
42.51%
8.48
0.93%
9.41
10.98%
free cash flow per share
0.01
-
0.01
23.16%
0.12
1,188.63%
0.14
21.65%
0.05
66.05%
0.26
423.89%
0.08
69.72%
0.06
20.19%
-0.09
250.99%
-0.14
46.56%
0.82
697.18%
free cash flow yield
0.00
-
0.00
36.72%
0.01
852.46%
0.01
7.85%
0.00
65.74%
0.02
511.20%
0.00
82.11%
0.00
55.44%
-0.00
317.44%
-0.01
49.03%
0.03
558.02%
graham net net
-1.36
-
-1.47
8.10%
-1.53
3.55%
-1.30
14.86%
1.26
197.29%
1.15
9.12%
1.14
0.45%
1.18
2.76%
2.96
151.67%
2.53
14.34%
2.88
13.55%
graham number
2.66
-
1.58
40.67%
0.45
71.30%
2.37
422.41%
5.98
152.71%
4.15
30.60%
5.95
43.27%
6.51
9.47%
8.61
32.15%
9.29
7.95%
9.50
2.32%
income quality
1.23
-
2.11
72.18%
4.09
93.75%
1.41
65.47%
0.18
87.60%
0.92
425.60%
0.72
22.01%
0.74
3.63%
0.92
23.20%
0.93
1.89%
2.19
134.01%
intangibles to total assets
0.04
-
0.03
8.66%
0.03
0.35%
0.03
4.49%
0.06
83.52%
0.08
26.35%
0.07
6.48%
0.07
4.47%
0.07
6.15%
0.09
19.13%
0.09
1.17%
interest coverage
18.51
-
2.24
87.89%
1.47
34.45%
3.55
141.31%
34.07
860.62%
144.39
323.81%
370.17
-
402.97
8.86%
593.98
47.40%
464.41
21.81%
interest debt per share
1.43
-
1.83
27.78%
1.65
9.74%
1.61
2.43%
0.29
82.22%
0.16
44.74%
0.27
69.25%
0.53
99.75%
0.32
40.78%
0.24
22.94%
0.09
62.51%
inventory turnover
0.90
-
0.95
5.21%
0.88
7.22%
0.98
11.28%
0.86
11.78%
0.91
4.78%
0.84
6.82%
0.80
5.42%
1.01
26.04%
0.93
7.53%
0.92
1.27%
invested capital
1.11
-
1.35
21.83%
1.17
12.82%
1.07
9.03%
0.13
87.99%
0.07
46.64%
0.10
48.57%
0.18
74.32%
0.06
64.35%
0.05
27.48%
0.01
67.34%
market cap
10.99B
-
13.26B
20.69%
17.42B
31.42%
20.49B
17.58%
20.08B
2.00%
17.16B
14.54%
29.03B
69.21%
52.25B
79.96%
39.02B
25.32%
39.45B
1.10%
50.98B
29.25%
net current asset value
-1.51B
-
-1.72B
13.83%
-1.64B
4.67%
-1.34B
18.14%
2.42B
280.44%
2.71B
12.14%
2.91B
7.25%
3.15B
8.14%
6.23B
98.18%
5.69B
8.80%
6.24B
9.65%
net debt to ebitda
1.99
-
2.73
37.22%
2.90
6.10%
2.19
24.50%
-1.03
146.96%
-1.02
1.17%
-0.86
15.18%
-0.76
11.43%
-2.70
253.27%
-2.07
23.09%
-1.36
34.64%
net income per share
0.25
-
0.09
65.28%
0.01
92.00%
0.17
2,417.03%
0.79
355.83%
0.34
56.69%
0.60
75.60%
0.63
4.97%
0.66
5.38%
0.72
9.66%
0.67
7.07%
operating cash flow per share
0.38
-
0.32
15.10%
0.32
1.94%
0.28
13.17%
0.15
48.44%
0.45
211.33%
0.43
5.19%
0.47
8.78%
0.61
29.83%
0.68
11.73%
1.47
117.47%
payables turnover
5.03
-
6.71
33.35%
6.46
3.66%
7.99
23.64%
32.03
300.79%
27.54
14.00%
32.96
19.66%
37.81
14.74%
29.28
22.58%
31.27
6.83%
35.13
12.31%
receivables turnover
4.80
-
5.98
24.74%
6.80
13.64%
6.34
6.72%
7.39
16.43%
6.24
15.56%
4.81
22.82%
4.70
2.29%
3.84
18.29%
3.48
9.53%
38.52
1,007.95%
research and ddevelopement to revenue
0.04
-
0.05
46.21%
0.07
33.85%
0.07
1.63%
0.04
39.38%
0.04
12.82%
0.04
0.60%
0.03
3.79%
0.03
6.89%
0.03
11.61%
0.03
9.50%
return on tangible assets
0.07
-
0.02
67.78%
0.00
91.70%
0.05
2,451.07%
0.34
631.68%
0.11
68.23%
0.15
40.11%
0.13
11.99%
0.10
25.85%
0.10
2.36%
0.09
15.89%
revenue per share
1.22
-
1.22
0.07%
1.11
8.81%
1.38
24.26%
1.18
14.82%
1.96
66.54%
2.19
12.02%
2.29
4.50%
2.54
10.97%
2.56
0.80%
3.11
21.49%
roe
0.19
-
0.07
65.75%
0.01
92.23%
0.12
2,221.45%
0.39
225.37%
0.15
61.06%
0.23
50.23%
0.21
8.06%
0.13
36.41%
0.14
3.19%
0.11
17.51%
roic
0.11
-
0.05
58.33%
0.03
46.03%
0.06
150.39%
0.36
473.59%
0.20
43.40%
0.21
1.20%
0.18
14.31%
0.12
29.49%
0.13
4.94%
0.14
8.67%
sales general and administrative to revenue
0.02
-
0.12
507.71%
0.04
68.46%
0.08
99.98%
0.05
39.23%
0.02
62.69%
0.02
9.51%
0.02
7.36%
0.02
0.84%
0.02
22.47%
0.02
2.75%
shareholders equity per share
1.28
-
1.29
1.39%
1.33
2.98%
1.45
8.42%
2.02
40.10%
2.25
11.22%
2.63
16.89%
3.00
14.17%
4.98
65.71%
5.29
6.26%
5.96
12.66%
stock based compensation to revenue
0.01
-
tangible asset value
1.97B
-
2.01B
2.37%
2.04B
1.54%
2.25B
10.20%
2.97B
31.63%
3.96B
33.69%
4.73B
19.36%
5.52B
16.71%
9.44B
70.91%
10.25B
8.63%
11.63B
13.43%
tangible book value per share
1.30
-
1.34
2.99%
1.40
4.53%
1.42
1.30%
1.97
38.91%
2.65
34.08%
3.16
19.41%
3.67
16.17%
5.84
58.91%
6.17
5.67%
7.06
14.43%
working capital
100.05M
-
-471.14M
570.89%
335.02M
171.11%
806.69M
140.78%
2.63B
225.54%
2.95B
12.35%
3.39B
15.05%
3.72B
9.50%
6.74B
81.23%
6.11B
9.25%
6.29B
2.88%

All numbers in (except ratios and percentages)